Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.7, 2011-07, pp. : 555-561

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are clinical trials worth it to insurers?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness Research: Improving Patient Care or Drug Rationing?

By Chou Roger

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 383-386

Adis International

Access to resources Recommend Favorite

Comparative effectiveness research: what future in the US?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness Research and Personalized Medicine: Catalyzing or Colliding?

By Epstein Robert S. Teagarden J. Russell

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 905-913

Adis International

Access to resources Recommend Favorite

Tax hikes, budget squeezes cost of maintaining current NHS funding?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 584, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite